−0.040CAD
−7.059MCAD
66.258M
About ALBERT LABS INTERNATIONAL CORP.
Sector
Industry
CEO
Michael Raymont
Website
Headquarters
Burnaby
ISIN
CA0127841041
Albert Labs International Corp. operates as a research and drug development company. It produces natural pharmaceutical-quality psilocybin medicine to treat cancer-related distress. The firm focuses on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways. The company is headquartered in Burnaby, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
